Finally, our analysis of public databases revealed that elevated expression and stemness of the genes SETD1B, CD24, and N-cadherin were significantly correlated with poorer prognosis in HCC patients' post-treatment (Figure 8H). Here, CDH2 is linked to hepatocellular carcinoma.